Sinergium Biotech is an Argentine pharmaceutical company specialized in the research, development, production and marketing of vaccines and highly complex biotechnology products. With unique characteristics worldwide, Sinergium Biotech carries forward an innovative production model of strategic alliances with national and international laboratories allowing: the transfer and availability of state-of-the-art technologies not available in the country, the autonomy in the production and supply of strategic products which had to be imported before now, the creation of new jobs with highly qualified professionals, the replacement of imports and the generation of a significant export potential; and thereupon, taking up a stance as regional leader in the production of vaccines and biotechnological products.
Situated in the locality of Garín, Province of Buenos Aires, Sinergium Biotech counts with a facility of 20.000 m2, has an annual production capacity of 30 million distributed in: 22 million of pre-filled syringes for vaccines and 4 million of vials plus 4 million of pre-filled syringes for biotechnology products.
Sinergium Biotech counts with quality control and follow-up systems through highly advanced technology equipment that guarantee the safety and efficacy of its products. The equipment and production process standards are compatible with the highest international rules of Good Manufacturing Practices (GMP – for the initials in English), complying with the guidelines of the North American regulatory agency Food & Drug Administration (FDA) and the European Medicines Agency (EMA). Sinergium Biotech also complies with the national regulations stated by the Administración Nacional de Medicamentos, Alimentos y Tecnología Médica (ANMAT) (National Administration of Drugs, Food and Medical Technology), which is in line with Mercosur.
September 11, 2016
Sinergium Biotech: an innovative production model